Sio Gene Therapies Inc. Common Stock

SIOX

Valor de mercado US$ 30,7 mi

Sobre: Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.

Funcionários: 12